Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New cancer care model brings treatment to local communities in thailand

NCT ID NCT07600294

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a specialized cancer care center could be set up in a local community clinic in Bangkok, Thailand, instead of a large hospital. Researchers included 358 patients, family members, and healthcare workers to see if the model improved access and satisfaction. The goal was to find a way to reduce the burden on major hospitals and make cancer care more affordable and trusted.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this model could make cancer care more accessible and affordable for communities in Thailand and similar settings.
What could go wrong
This is a feasibility study, not a test of a treatment. It cannot show if the model improves health outcomes or reduces costs in the long term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

358 people

The number who actually took part.

Started

Mar 2024

Finished

Jul 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Group 1: Service Recipients This group included patients and their family members who received services at the prototype center. The criteria for inclusion were the following: Age: Must be 20 years or older. Capacity: Must be able to express their opinions regarding the comprehensive cancer services. Consent: Must be willing to participate in the research study. Group 2: Service Providers This group consisted of 30 healthcare professionals (such as physicians, nurses, and pharmacists) directly involved in delivering care. The criteria for inclusion were: ,Age and Sex: Must be at least 20 years old; there were no restrictions regarding sex. Professional Status: Must be actively providing services at the Comprehensive Cancer Centre of Excellence or its affiliated network facilities. Knowledge Base: Must possess specific knowledge of the center's administrative and service systems. Consent: Must express a willingness to participate in the study. Group 3: Cancer Care Experts This group included 15 experts (administrators, academics, and researchers) who provided qualitative evaluation. The criteria for inclusion were: Professional Experience: Must have a minimum of five years of experience in the field of cancer care. Expertise: Must have the ability to provide deep insights into comprehensive cancer services. Consent: Must be willing to participate in the research. Note: There were no restrictions regarding the sex or age of these experts. Exclusion Criteria: * Group 1 (Service Recipients): Participants were required to be at least 20 years old, have the ability to express their opinions regarding the center's services, and be willing to participate in the study. Group 2 (Service Providers): Eligible healthcare professionals had to be at least 20 years old, be actively providing services at the prototype center or its affiliated facilities, and possess specific knowledge of the center's administrative and service systems. Group 3 (Cancer Care Experts): These individuals were required to have a minimum of five years of experience in cancer care and the capacity to provide deep insights into comprehensive cancer services. The sources note there were no restrictions regarding the sex or age of these experts

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Princess Agrarajakumari Faculty of Nursing, Chulabhorn Royal Academy

    Bangkok, 10210, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.